Description
Professor Saltzman uses cancer diagnosis and treatment as an example to demonstrate the some applications of biomedical engineering technologies and methods. Some issues involved in cancer treatment, such as tumor angiogenesis, radiation sensitivity, drug localization, and cancer stem cells are mentioned. Next, he describes the phases (I-IV), in compliance to guidelines enforced by the Food and Drug Administration (FDA), which a new drug compound must go through to gain approval prior to public distribution/sale. Finally, Professor Saltzman draws attention to the areas that biomedical engineers may contribute to, to improve this process.
In this final lecture, Professor Saltzman talks about artificial organs, with a stress on synthetic biomaterials. First, the body's responses (immunological and scar healing responses) to foreign materials are introduced. This leads to discussion of different types of polymer/plastic materials...
Published 10/12/09
In this lecture, Professor Saltzman continues his discussion of tissue engineering, and its role in facilitating healing, tissue regeneration, organ replacement, drug delivery and as model for studying human physiology. Specific examples from current research by scientists at Yale are used to...
Published 10/12/09
Professor Saltzman motivates the need for tissue engineering, and describes the basic elements of the tissue engineering approach. Professor Saltzman defines three different types of tissue transplants: autografts, allografts, and xenografts. An online resource for organ donors/recipients is...
Published 10/12/09